Ovarian cancer protein study aims to guide future treatments
NCT ID NCT07407062
First seen Feb 24, 2026 · Last updated May 23, 2026 · Updated 14 times
Summary
This study looks at tissue samples from 200 people with relapsed ovarian, fallopian tube, or primary peritoneal cancer to measure a protein called folate receptor alpha. The goal is to see how common high levels of this protein are at first diagnosis and after the cancer returns. No new treatments are given—this is purely an observation study to help design better therapies in the future.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER - OVARIAN are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.